scispace - formally typeset
M

Megan Bohensky

Researcher at University of Melbourne

Publications -  72
Citations -  25930

Megan Bohensky is an academic researcher from University of Melbourne. The author has contributed to research in topics: Population & Poison control. The author has an hindex of 26, co-authored 72 publications receiving 21558 citations. Previous affiliations of Megan Bohensky include Monash University, Clayton campus & Monash University.

Papers
More filters
Journal ArticleDOI

Implications of vision testing for older driver licensing.

TL;DR: The findings of the review indicate that the predictive values of the vision tests commonly used for licensing decisions by the selected authorities are inconclusive, and decisions about vision for safe driving need to be considered in the context of the driver's overall health and other functional abilities.
Journal ArticleDOI

Do older drivers pose a risk to other road users

TL;DR: It has been strongly asserted that overall, the older the driver, the less the threat to other road users—and particularly, to road users external to the driver's vehicle.
Journal ArticleDOI

Adverse outcomes associated with elective knee arthroscopy: a population-based cohort study

TL;DR: The frequency of adverse outcomes after elective knee arthroscopies in Victoria, Australia, was quantified and potential risk factors for complications were older age, presence of comorbidity, being married, major mechanical issues, and having the procedure performed in a public hospital.
Journal ArticleDOI

Development and validation of reporting guidelines for studies involving data linkage

TL;DR: Data or record linkage is commonly used to combine existing data sets for the purpose of creating more comprehensive information to conduct research, but may create additional concerns about error if cases are not linked accurately.
Journal ArticleDOI

Mapping the patterns of care, the receipt of palliative care and the site of death for patients with malignant glioma

TL;DR: In this article, the association between malignant glioma patients with a high burden of symptoms and palliative care and their site of death was quantified, and it was shown that patients with high burden were more likely to die at home.